Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Trubion Pharmaceuticals Inc.

Levi & Korsinsky is investigating the Board of Directors of Trubion Pharmaceuticals Inc. (“Trubion” or the “Company”) (NasdaqGM: TRBN) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Emergent BioSolutions Inc. ("Emergent") (NYSE: EBS). Under the terms of the transaction, each share of Trubion common stock will be converted into the right to receive an upfront payment of $1.365 per share in cash and 0.1641 shares of Emergent common stock. Based on Emergent's common stock price for the prior five days, the upfront payment represents a value of $4.55 per share, or approximately $96.8 million in the aggregate. Trubion shareholders will also receive one Contingent Value Right ("CVR") per share, which will entitle the holder to receive cash payments based upon the achievement of certain milestones. The total potential aggregate value of the CVRs is $38.7 million over a 36-month period.

The investigation concerns whether the Trubion Board of Directors breached their fiduciary duties to Trubion stockholders by failing to adequately shop the Company before entering into this transaction and whether Emergent is underpaying for Trubion shares, thus unlawfully harming Trubion stockholders. In particular, at least one analyst set a price target for Trubion stock at $7.00 per share.

If you own common stock in Trubion and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500 or visit http://www.zlk.com/trubion-pharmaceuticals-trbn.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.

Trubion Pharmaceuticals (MM) (NASDAQ:TRBN)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024